Generation and analysis of mice with a targeted disruption of the arylamine N-acetyltransferase type 2 gene

被引:43
|
作者
Cornish, VA
Pinter, K
Boukouvala, S
Johnson, N
Labrousse, C
Payton, M
Priddle, H
Smith, AJH
Sim, E
机构
[1] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England
[2] Univ Edinburgh, Inst Stem Cell Res, Gene Targeting Lab, Edinburgh, Midlothian, Scotland
来源
PHARMACOGENOMICS JOURNAL | 2003年 / 3卷 / 03期
关键词
arylamine N-acetyltransferase; mouse; knockout; teratology; folate;
D O I
10.1038/sj.tpj.6500170
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Arylamine N-acetyltransferases (NATs) are polymorphic xenobiotic metabolising enzymes, linked to cancer susceptibility in a variety of tissues. In humans and in mice there are multiple NAT isoforms. To identify whether the different isoforms represent inbuilt redundancy or whether they have unique roles, we have generated mice with a null allele of Nat2 by gene targeting. This mouse line conclusively demonstrates that the different isoforms have distinct functions with no compensatory expression in the Nat2 null animals of the other isoforms. In addition, we have used the transgenic line to show the pattern of Nat2 expression during development. Although Nat2 is not essential for embryonic development, it has a widespread tissue distribution from at least embryonic day 9.5. This mouse line now paves the way for the teratological role of Nat2 to be tested.
引用
收藏
页码:169 / 177
页数:9
相关论文
共 50 条
  • [1] Generation and analysis of mice with a targeted disruption of the arylamine N-acetyltransferase type 2 gene
    V A Cornish
    K Pinter
    S Boukouvala
    N Johnson
    C Labrousse
    M Payton
    H Priddle
    A J H Smith
    E Sim
    The Pharmacogenomics Journal, 2003, 3 : 169 - 177
  • [2] ARYLAMINE N-ACETYLTRANSFERASE
    SIM, E
    HICKMAN, D
    CORONEOS, E
    KELLY, SL
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1992, 20 (02) : 304 - 309
  • [3] Arylamine N-acetyltransferase 2 gene polymorphism in an Algerian population
    Chelouti, Hiba
    Khelil, Malika
    ANNALS OF HUMAN BIOLOGY, 2017, 44 (06) : 531 - 536
  • [4] Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding
    Nicola Laurieri
    Akane Kawamura
    Isaac M Westwood
    Amy Varney
    Elizabeth Morris
    Angela J Russell
    Lesley A Stanley
    Edith Sim
    BMC Pharmacology and Toxicology, 15
  • [5] Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding
    Laurieri, Nicola
    Kawamura, Akane
    Westwood, Isaac M.
    Varney, Amy
    Morris, Elizabeth
    Russell, Angela J.
    Stanley, Lesley A.
    Sim, Edith
    BMC PHARMACOLOGY & TOXICOLOGY, 2014, 15
  • [6] Arylamine N-acetyltransferase I
    Minchin, Rodney F.
    Hanna, Patrick E.
    Dupret, Jean-Marie
    Wagner, Carston R.
    Rodrigues-Lima, Fernando
    Butcher, Neville J.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (11): : 1999 - 2005
  • [7] Changes in consensus arylamine N-acetyltransferase gene nomenclature
    Hein, David W.
    Boukouvala, Sotiria
    Grant, Denis M.
    Minchin, Rodney F.
    Sim, Edith
    PHARMACOGENETICS AND GENOMICS, 2008, 18 (04): : 367 - 368
  • [8] Update on consensus arylamine N-acetyltransferase gene nomenclature
    Hein, DW
    Grant, DM
    Sim, E
    PHARMACOGENETICS, 2000, 10 (04): : 291 - 292
  • [9] Kinetic characterization of arylamine N-acetyltransferase 2
    Baker, Inesha
    Parker, Chasta L.
    FASEB JOURNAL, 2008, 22
  • [10] Catalytic mechanism of hamster arylamine N-acetyltransferase 2
    Wang, HQ
    Liu, L
    Hanna, PE
    Wagner, CR
    BIOCHEMISTRY, 2005, 44 (33) : 11295 - 11306